Literature DB >> 15653315

Antigen presentation and recognition in bacterial infections.

Stefan He Kaufmann1, Ulrich E Schaible.   

Abstract

Antigen processing and recognition is a key feature of antibacterial immune responses to intracellular bacteria. In contrast to viruses, which are primarily controlled by conventional MHC II- and MHC I-restricted CD4+ or CD8+ T cells, respectively, unconventional T cells participate additionally in antibacterial protection. These unconventional T cells include glycolipid-specific CD1-restricted T cells and phospholigand-specific gammadelta T cells. We are just beginning to understand the broad spectrum of antigen recognition and stimulation of distinct T-cell populations by bacterial pathogens. From the host perspective, a broad spectrum of different T-cell populations that recognize proteins, lipids and carbohydrates strengthens protective immunity. From the perspective of the pathogen, antigen presentation represents a bottleneck that should be exploited for evasion from, or devastation of, acquired immunity. Although several such mechanisms have been described in viral systems, few have thus far been elucidated in bacterial infections.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15653315     DOI: 10.1016/j.coi.2004.12.004

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  23 in total

1.  T Cells Capture Bacteria by Transinfection from Dendritic Cells.

Authors:  Aranzazu Cruz-Adalia; Guillermo Ramírez-Santiago; Mónica Torres-Torresano; Raquel Garcia-Ferreras; Esteban Veiga Chacón
Journal:  J Vis Exp       Date:  2016-01-13       Impact factor: 1.355

2.  Generation of CD8+ T-cell responses by a recombinant nonpathogenic Mycobacterium smegmatis vaccine vector expressing human immunodeficiency virus type 1 Env.

Authors:  Mark J Cayabyab; Avi-Hai Hovav; Tsungda Hsu; Georgia R Krivulka; Michelle A Lifton; Darci A Gorgone; Glenn J Fennelly; Barton F Haynes; William R Jacobs; Norman L Letvin
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Nucleotide-binding and oligomerization domain-like receptors and retinoic acid inducible gene-like receptors in human tonsillar T lymphocytes.

Authors:  Terese Petterson; Anne Månsson; Kristian Riesbeck; Lars O Cardell
Journal:  Immunology       Date:  2011-02-22       Impact factor: 7.397

Review 4.  Mycobacterium tuberculosis and the intimate discourse of a chronic infection.

Authors:  David G Russell
Journal:  Immunol Rev       Date:  2011-03       Impact factor: 12.988

5.  Aspirin significantly decreases the nonopsonic phagocytosis and immunogenicity of macrophages in mice.

Authors:  Aqeel Javeed; Yuzhu Hou; Kaizhong Duan; Baojun Zhang; Hong Shen; Yuhong Cao; Yong Zhao
Journal:  Inflamm Res       Date:  2010-12-01       Impact factor: 4.575

6.  Stimulation of CD8+ T cells following diphtheria toxin-mediated antigen delivery into dendritic cells.

Authors:  Christine A Shaw; Michael N Starnbach
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

7.  Targeting γδ T cells for immunotherapy of HIV disease.

Authors:  C David Pauza; David J Riedel; Bruce L Gilliam; Robert R Redfield
Journal:  Future Virol       Date:  2011-01-01       Impact factor: 1.831

8.  Microbial carbohydrate depolymerization by antigen-presenting cells: deamination prior to presentation by the MHCII pathway.

Authors:  Jinyou Duan; Fikri Y Avci; Dennis L Kasper
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-01       Impact factor: 11.205

9.  Regulatory T cells modulate staphylococcal enterotoxin B-induced effector T-cell activation and acceleration of colitis.

Authors:  Armando Heriazon; Pengfei Zhou; Rajka Borojevic; Katharina Foerster; Catherine J Streutker; Terry Ng; Kenneth Croitoru
Journal:  Infect Immun       Date:  2008-12-08       Impact factor: 3.441

10.  Dendritic cell cross-priming is essential for immune responses to Listeria monocytogenes.

Authors:  Anna T Reinicke; Kyla D Omilusik; Genc Basha; Wilfred A Jefferies
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.